- GlobeNewswire•22 days agoAnthera Pharmaceuticals Announces Initial $17.0 Million Closing of a Potential $45.33 Million Registered Direct Offering to Biotechnology Value Fund and Rock Springs Capital
HAYWARD, Calif., Sept. 08, 2016-- Anthera Pharmaceuticals, Inc. today announced that it has agreed to sell preferred convertible stock in two tranches to Biotechnology Value Fund, L.P. and other affiliates ...
- GlobeNewswire•last month
HAYWARD, Calif., Aug. 16, 2016-- Anthera Pharmaceuticals, Inc. today announced the appointment of William Shanahan, M.D., J.D. as Chief Medical Officer. In his role as Chief Medical Officer, Dr. Shanahan ...
Anthera Pharmaceuticals, Inc. (ANTH)
NasdaqGM - NasdaqGM Delayed Price. Currency in USD
|Bid||3.00 x 1000|
|Ask||3.23 x 300|
|Day's Range||3.05 - 3.24|
|52wk Range||2.28 - 7.15|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-2.82|
|Avg Vol (3m)||474,479|
|Dividend & Yield||N/A (N/A)|